Cutting off cancer cells’ access to fat may help a specific type of cancer treatment work more effectively, reports a study by Van Andel Institute scientists.
A scrap of data on Amgen’s obesity drug candidate wipes out $12 billion in market value
On Tuesday, a tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value. The data,